Savara Inc Interest Income (Expense), Nonoperating, Net
Savara Inc (SVRA) reported Interest Income (Expense), Nonoperating, Net of $829.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-11
- Savara Inc interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $829.00K, a 9.99% decline year-over-year.
- Savara Inc interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $1.06M, a 29.44% decline year-over-year.
- Savara Inc interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $1.20M, a 37.53% decline year-over-year.
- Savara Inc interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $548.00K, a 74.26% decline year-over-year.
- Savara Inc interest income (expense), nonoperating, net for fiscal 2025 was $4.16M, a 35.64% decline from fiscal 2024.
- Savara Inc interest income (expense), nonoperating, net for fiscal 2024 was $6.47M, a 45.78% increase from fiscal 2023.
- Savara Inc interest income (expense), nonoperating, net for fiscal 2023 was $4.44M.
- Savara Inc interest income (expense), nonoperating, net for fiscal 2022 was -$88.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $829.00K 10-Q · filed 2026-08-11 | $1.91M 10-Q · filed 2026-08-11 | $3.08M derived: sum of 3 quarters · filed 2026-08-11 | $3.63M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-12 | $2.25M derived: sum of 2 quarters · filed 2026-05-12 | $2.80M derived: sum of 3 quarters · filed 2026-05-12 | $3.72M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $1.74M derived: sum of 2 quarters · filed 2026-03-13 | $2.66M derived: sum of 3 quarters · filed 2026-08-11 | $4.16M 10-K · filed 2026-03-13 |
| 2025-09-30 | $548.00K 10-Q · filed 2025-11-12 | $1.47M derived: sum of 2 quarters · filed 2026-08-11 | $2.97M 10-Q · filed 2025-11-12 | $4.88M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $921.00K 10-Q · filed 2026-08-11 | $2.42M 10-Q · filed 2026-08-11 | $4.33M derived: sum of 3 quarters · filed 2026-08-11 | $6.46M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-12 | $3.41M derived: sum of 2 quarters · filed 2026-05-12 | $5.54M derived: sum of 3 quarters · filed 2026-05-12 | $6.61M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $4.04M derived: sum of 2 quarters · filed 2026-03-13 | $5.11M derived: sum of 3 quarters · filed 2026-03-13 | $6.47M 10-K · filed 2026-03-13 |
| 2024-09-30 | $2.13M 10-Q · filed 2025-11-12 | $3.20M derived: sum of 2 quarters · filed 2025-11-12 | $4.55M 10-Q · filed 2025-11-12 | $6.07M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.07M 10-Q · filed 2025-08-13 | $2.42M 10-Q · filed 2025-08-13 | $3.94M derived: sum of 3 quarters · filed 2025-08-13 | $5.39M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.35M 10-Q · filed 2025-05-13 | $2.87M derived: sum of 2 quarters · filed 2025-05-13 | $4.32M derived: sum of 3 quarters · filed 2025-05-13 | $5.03M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.96M derived: sum of 2 quarters · filed 2025-03-27 | $3.67M derived: sum of 3 quarters · filed 2025-03-27 | $4.44M 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.44M 10-Q · filed 2024-11-12 | $2.15M derived: sum of 2 quarters · filed 2024-11-12 | $2.92M 10-Q · filed 2024-11-12 | $3.53M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $709.00K 10-Q · filed 2024-08-12 | $1.47M 10-Q · filed 2024-08-12 | $2.09M derived: sum of 3 quarters · filed 2024-08-12 | $2.24M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $765.00K 10-Q · filed 2024-05-09 | $1.38M derived: sum of 2 quarters · filed 2024-05-09 | $1.53M derived: sum of 3 quarters · filed 2024-05-09 | $1.25M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $766.00K derived: sum of 2 quarters · filed 2024-03-07 | $482.00K derived: sum of 3 quarters · filed 2024-03-07 | -$88.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $152.00K 10-Q · filed 2023-11-09 | -$132.00K derived: sum of 2 quarters · filed 2023-11-09 | -$702.00K 10-Q · filed 2023-11-09 | -$1.27M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$284.00K 10-Q · filed 2023-08-10 | -$854.00K 10-Q · filed 2023-08-10 | -$1.42M derived: sum of 3 quarters · filed 2023-08-10 | -$1.99M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$570.00K 10-Q · filed 2023-05-15 | -$1.14M derived: sum of 2 quarters · filed 2023-05-15 | -$1.70M derived: sum of 3 quarters · filed 2023-05-15 | -$2.26M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.13M derived: sum of 2 quarters · filed 2023-03-30 | -$1.69M derived: sum of 3 quarters · filed 2023-03-30 | -$2.28M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$566.00K 10-Q · filed 2022-11-10 | -$1.12M derived: sum of 2 quarters · filed 2022-11-10 | -$1.72M 10-Q · filed 2022-11-10 | -$2.25M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$558.00K 10-Q · filed 2022-08-11 | -$1.15M 10-Q · filed 2022-08-11 | -$1.68M derived: sum of 3 quarters · filed 2022-08-11 | -$2.14M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$593.00K 10-Q · filed 2022-05-11 | -$1.12M derived: sum of 2 quarters · filed 2022-05-11 | -$1.58M derived: sum of 3 quarters · filed 2022-05-11 | -$1.91M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$989.00K derived: sum of 2 quarters · filed 2022-03-30 | -$1.32M derived: sum of 3 quarters · filed 2022-03-30 | -$1.48M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$459.00K 10-Q · filed 2021-11-12 | -$791.00K derived: sum of 2 quarters · filed 2021-11-12 | -$952.00K 10-Q · filed 2021-11-12 | -$1.04M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$332.00K 10-Q · filed 2021-08-12 | -$493.00K 10-Q · filed 2021-08-12 | -$578.00K derived: sum of 3 quarters · filed 2021-08-12 | -$573.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$160.00K 10-Q · filed 2021-05-13 | -$246.00K derived: sum of 2 quarters · filed 2021-05-13 | -$241.00K derived: sum of 3 quarters · filed 2021-05-13 | -$210.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$81.00K derived: sum of 2 quarters · filed 2021-03-10 | -$50.00K derived: sum of 3 quarters · filed 2021-03-10 | -$70.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-05 | $36.00K derived: sum of 2 quarters · filed 2020-11-05 | $16.00K 10-Q · filed 2020-11-05 | $133.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $31.00K 10-Q · filed 2020-08-06 | $11.00K 10-Q · filed 2020-08-06 | $128.00K derived: sum of 3 quarters · filed 2020-08-06 | $239.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$20.00K 10-Q · filed 2020-05-07 | $97.00K derived: sum of 2 quarters · filed 2020-05-07 | $208.00K derived: sum of 3 quarters · filed 2020-05-07 | $95.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $228.00K derived: sum of 2 quarters · filed 2020-03-12 | $115.00K derived: sum of 3 quarters · filed 2020-03-12 | $11.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $111.00K 10-Q · filed 2019-11-07 | -$2.00K derived: sum of 2 quarters · filed 2019-11-07 | -$106.00K 10-Q · filed 2019-11-07 | -$229.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$113.00K 10-Q · filed 2019-08-08 | -$217.00K 10-Q · filed 2019-08-08 | -$340.00K derived: sum of 3 quarters · filed 2019-08-08 | -$617.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$104.00K 10-Q · filed 2019-05-09 | -$227.00K derived: sum of 2 quarters · filed 2019-05-09 | -$504.00K derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$400.00K derived: sum of 2 quarters · filed 2019-03-13 | -$1.16M 10-K · filed 2019-03-13 | |
| 2017-09-30 | -$277.00K 10-Q · filed 2018-11-07 | -$1.04M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |